Biomarkers Market to 2025 - Global Analysis and Forecasts by Type (Efficacy, Safety, Validation); By Product (Software, Services, Consumables); By Disease Detection (Cancer, Neurological Immunological, Cardiovascular, and Other Diseases) and By Application (Drug Discovery, Personalized Medicine, Diagnostic Development, Disease Risk Assessment, and Other Applications)
Report Code: TIPHE100000974 No. of Pages: 150 Category: Biotechnology Status: Upcoming
Biomarker is an indicator used to evaluate the health status of an individual. In medical terms, a measurable biomarker is a chemical component which reflects the presence as well as the severity of the disease. Biomarkers have an important function in the early detection of various diseases. These compounds are introduced into the body in order to estimate the health condition of an individual. The biomarker reacts with the target molecule or cell within the body. The byproducts of the chemical reaction between the biomarker and the target molecule is analyzed with the help of various tests to evaluate the severity of a disease in an individual.
Growing incidence of cancer & neurological diseases and increasing availability of funds for biomarker research are anticipated to be the driving factors for the growth of biomarkers market. Rise in the use of biomarkers for disease detection in Asian economies such as, China and India is expected to provide growth opportunities to the players operating in the market in the future years.
The "Global Biomarkers Market Analysis to 2025" is a specialized and in-depth study of the biomarkers industry with a focus on the global market trend. The report aims to provide an overview of global biomarkers market with detailed market segmentation by type, product, disease detection, application, and geography. The global biomarkers market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The biomarkers market is segmented based on type as, efficacy biomarkers, safety biomarkers and validation biomarkers. Efficacy biomarkers are further classified as pharmacodynamic, prognostive and predictive biomarkers. Based on products, the market is segmented as software, services and consumables. The market is categorized by the disease detection as, cancer, neurological disease, immunological disease, cardiovascular, and other diseases. Based on application, the market is categorized as, drug discovery, personalized medicine, diagnostic development, disease risk assessment, and other diseases.
The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global biomarkers market based on type, product, disease detection, and application. It also provides market size and forecast till 2025 for overall biomarkers market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.
Europe is anticipated to dominate the biomarkers market in the global scenario owing to various technological developments in the healthcare industry and rising research activities in UK and Germany. Asia Pacific market is expected to witness significant growth rate during the forecast period owing to the opportunities in the emerging economies.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key biomarkers manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market Thermo Fisher Scientific Inc., Qiagen, Hologic Inc., F. Hoffmann-La Roche Ltd., Janssen Global Services, LLC., Siemens Healthcare GmbH, Cisbio, Biomarker Technologies, Inc., Becton, Dickinson and Company, and Bio-Rad Laboratories, Inc. among Others.
Growing incidence of cancer & neurological diseases and increasing availability of funds for biomarker research are anticipated to be the driving factors for the growth of biomarkers market. Rise in the use of biomarkers for disease detection in Asian economies such as, China and India is expected to provide growth opportunities to the players operating in the market in the future years.
The "Global Biomarkers Market Analysis to 2025" is a specialized and in-depth study of the biomarkers industry with a focus on the global market trend. The report aims to provide an overview of global biomarkers market with detailed market segmentation by type, product, disease detection, application, and geography. The global biomarkers market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The biomarkers market is segmented based on type as, efficacy biomarkers, safety biomarkers and validation biomarkers. Efficacy biomarkers are further classified as pharmacodynamic, prognostive and predictive biomarkers. Based on products, the market is segmented as software, services and consumables. The market is categorized by the disease detection as, cancer, neurological disease, immunological disease, cardiovascular, and other diseases. Based on application, the market is categorized as, drug discovery, personalized medicine, diagnostic development, disease risk assessment, and other diseases.
The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global biomarkers market based on type, product, disease detection, and application. It also provides market size and forecast till 2025 for overall biomarkers market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.
Europe is anticipated to dominate the biomarkers market in the global scenario owing to various technological developments in the healthcare industry and rising research activities in UK and Germany. Asia Pacific market is expected to witness significant growth rate during the forecast period owing to the opportunities in the emerging economies.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key biomarkers manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market Thermo Fisher Scientific Inc., Qiagen, Hologic Inc., F. Hoffmann-La Roche Ltd., Janssen Global Services, LLC., Siemens Healthcare GmbH, Cisbio, Biomarker Technologies, Inc., Becton, Dickinson and Company, and Bio-Rad Laboratories, Inc. among Others.
1 Introduction
1.1 Scope of Study
1.2 The Insight Partners Research Report Guidance
2 Key Takeaways
3 Biomarkers Market Landscape
3.1 Market Overview
3.2 Market Segmentation
3.2.1 Biomarkers Market - By Type
3.2.2 Biomarkers Market - By Product
3.2.3 Biomarkers Market - By Disease Detection
3.2.4 Biomarkers Market - By Application
3.2.5 Biomarkers Market - By Region
3.2.5.1 By Country
3.3 PEST Analysis
3.3.1 North America - PEST Analysis
3.3.2 Europe - PEST Analysis
3.3.3 Asia Pacific - PEST Analysis
3.3.4 Middle East and Africa - PEST Analysis
3.3.5 South and Central America - PEST Analysis
4 Biomarkers Market - Key Industry Dynamics
4.1 Key Market Drivers
4.2 Key Market Restraints
4.3 Key Market Opportunities
4.4 Future Trends
4.5 Impact Analysis
5 Biomarkers Market - Global Analysis
5.1 Global Biomarkers Market Overview
5.2 Global Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
5.3 Market Positioning/Market Share
5.4 Performance of Key Players
5.5 Clinical Trial Analysis
5.6 Expert Opinions
6 Biomarkers Market Revenue and Forecasts to 2025 - Type (US$ Mn)
6.1 Overview
6.2 Type Market Forecasts and Analysis
6.3 Efficacy Biomarkers Market
6.3.1 Overview
6.3.2 Efficacy Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
6.3.3 Pharmacodynamic Biomarkers Market
6.3.3.1 Overview
6.3.3.2 Pharmacodynamic Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
6.3.4 Prognostic Biomarkers Market
6.3.4.1 Overview
6.3.4.2 Prognostic Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
6.3.5 Predictive Biomarkers Market
6.3.5.1 Overview
6.3.5.2 Predictive Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
6.4 Safety Biomarkers Market
6.4.1 Overview
6.4.2 Safety Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
6.5 Validation Biomarkers Market
6.5.1 Overview
6.5.2 Validation Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
7 Biomarkers Market Revenue and Forecasts to 2025 - Product (US$ Mn)
7.1 Overview
7.2 Product Market Forecasts and Analysis
7.3 Software Market
7.3.1 Overview
7.3.2 Software Market Revenue Forecasts and Analysis (US$ Mn)
7.4 Services Market
7.4.1 Overview
7.4.2 Services Market Revenue Forecasts and Analysis (US$ Mn)
7.5 Consumables Market
7.5.1 Overview
7.5.2 Consumables Market Revenue Forecasts and Analysis (US$ Mn)
8 Biomarkers Market Revenue and Forecasts to 2025 - Disease Detection (US$ Mn)
8.1 Overview
8.2 Disease Detection Market Forecasts and Analysis
8.3 Cancer Market
8.3.1 Overview
8.3.2 Cancer Market Revenue Forecasts and Analysis (US$ Mn)
8.4 Neurological Disease Market
8.4.1 Overview
8.4.2 Neurological Disease Market Revenue Forecasts and Analysis (US$ Mn)
8.5 Immunological Disease Market
8.5.1 Overview
8.5.2 Immunological Disease Market Revenue Forecasts and Analysis (US$ Mn)
8.6 Cardiovascular Disease Market
8.6.1 Overview
8.6.2 Cardiovascular Disease Market Revenue Forecasts and Analysis (US$ Mn)
8.7 Other Disease Detections Market
8.7.1 Overview
8.7.2 Other Disease Market Revenue Forecasts and Analysis (US$ Mn)
9 Biomarkers Market Revenue and Forecasts to 2025 - Application (US$ Mn)
9.1 Overview
9.2 Application Market Forecasts and Analysis
9.3 Drug Discovery Market
9.3.1 Overview
9.3.2 Drug Discovery Market Revenue Forecasts and Analysis (US$ Mn)
9.4 Personalized Medicine Market
9.4.1 Overview
9.4.2 Personalized Medicine Market Revenue Forecasts and Analysis (US$ Mn)
9.5 Diagnostic Development Market
9.5.1 Overview
9.5.2 Diagnostic Development Market Revenue Forecasts and Analysis (US$ Mn)
9.6 Disease Risk Assessment Market
9.6.1 Overview
9.6.2 Disease Risk Assessment Market Revenue Forecasts and Analysis (US$ Mn)
9.7 Other Applications Market
9.7.1 Overview
9.7.2 Other Applications Market Revenue Forecasts and Analysis (US$ Mn)
10 North America Biomarkers Market Revenue and Forecasts to 2025 - Country Analysis
10.1 North America Biomarkers Market Overview
10.2 North America Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
10.3 North America Market Forecasts and Analysis - By Type
10.3.1 North America Market Type Revenue Forecasts and Analysis - By Efficacy Biomarkers (US$ Mn)
10.4 North America Market Forecasts and Analysis - By Product
10.5 North America Market Forecasts and Analysis - By Disease Detection
10.6 North America Market Forecasts and Analysis - By Application
10.7 North America Market Forecasts and Analysis - By Country
10.8 US Market Overview
10.8.1 US Biomarkers Market Revenue Forecasts and Analysis-By Type (US$ Mn)
10.8.1.1 US Biomarkers Type Market Revenue Forecasts and Analysis-By Efficacy Biomarkers (US$ Mn)
10.8.2 US Biomarkers Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.8.3 US Biomarkers Market Revenue Forecasts and Analysis-By Disease Detection (US$ Mn)
10.8.4 US Biomarkers Market Revenue Forecasts and Analysis-By Application (US$ Mn)
10.9 Canada Market Overview
10.9.1 Canada Biomarkers Market Revenue Forecasts and Analysis-By Type (US$ Mn)
10.9.1.1 Canada Biomarkers Type Market Revenue Forecasts and Analysis-By Efficacy Biomarkers (US$ Mn)
10.9.2 Canada Biomarkers Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.9.3 Canada Biomarkers Market Revenue Forecasts and Analysis-By Disease Detection (US$ Mn)
10.9.4 Canada Biomarkers Market Revenue Forecasts and Analysis-By Application (US$ Mn)
10.10 Mexico Market Overview
10.10.1 Mexico Biomarkers Market Revenue Forecasts and Analysis-By Type (US$ Mn)
10.10.1.1 Mexico Biomarkers Type Market Revenue Forecasts and Analysis-By Efficacy Biomarkers (US$ Mn)
10.10.2 Mexico Biomarkers Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.10.3 Mexico Biomarkers Market Revenue Forecasts and Analysis-By Disease Detection (US$ Mn)
10.10.4 Mexico Biomarkers Market Revenue Forecasts and Analysis-By Application (US$ Mn)
`
11 Europe Biomarkers Market Revenue and Forecasts to 2025 - Country Analysis
11.1 Europe Biomarkers Market Overview
11.2 Europe Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
11.3 Europe Market Forecasts and Analysis - By Type
11.3.1 Europe Market Type Revenue Forecasts and Analysis - By Efficacy Biomarkers (US$ Mn)
11.4 Europe Market Forecasts and Analysis - By Product
11.5 Europe Market Forecasts and Analysis - By Disease Detection
11.6 Europe Market Forecasts and Analysis - By Application
11.7 Europe Market Forecasts and Analysis - By Country
11.8 UK Market Overview
11.8.1 UK Biomarkers Market Revenue Forecasts and Analysis-By Type (US$ Mn)
11.8.1.1 UK Biomarkers Type Market Revenue Forecasts and Analysis-By Efficacy Biomarkers (US$ Mn)
11.8.2 UK Biomarkers Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.8.3 UK Biomarkers Market Revenue Forecasts and Analysis-By Disease Detection (US$ Mn)
11.8.4 UK Biomarkers Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.9 Germany Market Overview
11.9.1 Germany Biomarkers Market Revenue Forecasts and Analysis-By Type (US$ Mn)
11.9.1.1 Germany Biomarkers Type Market Revenue Forecasts and Analysis-By Efficacy Biomarkers (US$ Mn)
11.9.2 Germany Biomarkers Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.9.3 Germany Biomarkers Market Revenue Forecasts and Analysis-By Disease Detection (US$ Mn)
11.9.4 Germany Biomarkers Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.10 France Market Overview
11.10.1 France Biomarkers Market Revenue Forecasts and Analysis-By Type (US$ Mn)
11.10.1.1 France Biomarkers Type Market Revenue Forecasts and Analysis-By Efficacy Biomarkers (US$ Mn)
11.10.2 France Biomarkers Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.10.3 France Biomarkers Market Revenue Forecasts and Analysis-By Disease Detection (US$ Mn)
11.10.4 France Biomarkers Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12 Asia Pacific Biomarkers Market Revenue and Forecasts to 2025 - Country Analysis
12.1 Asia Pacific Biomarkers Market Overview
12.2 Asia Pacific Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
12.3 Asia Pacific Market Forecasts and Analysis - By Type
12.3.1 Asia Pacific Market Type Revenue Forecasts and Analysis - By Efficacy Biomarkers (US$ Mn)
12.4 Asia Pacific Market Forecasts and Analysis - By Product
12.5 Asia Pacific Market Forecasts and Analysis - By Disease Detection
12.6 Asia Pacific Market Forecasts and Analysis - By Application
12.7 Asia Pacific Market Forecasts and Analysis - By Country
12.8 Japan Market Overview
12.8.1 Japan Biomarkers Market Revenue Forecasts and Analysis-By Type (US$ Mn)
12.8.1.1 Japan Biomarkers Type Market Revenue Forecasts and Analysis-By Efficacy Biomarkers (US$ Mn)
12.8.2 Japan Biomarkers Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.8.3 Japan Biomarkers Market Revenue Forecasts and Analysis-By Disease Detection (US$ Mn)
12.8.4 Japan Biomarkers Market Revenue Forecasts and Analysis-By Application (US$ Mn)
?
12.9 China Market Overview
12.9.1 China Biomarkers Market Revenue Forecasts and Analysis-By Type (US$ Mn)
12.9.1.1 China Biomarkers Type Market Revenue Forecasts and Analysis-By Efficacy Biomarkers (US$ Mn)
12.9.2 China Biomarkers Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.9.3 China Biomarkers Market Revenue Forecasts and Analysis-By Disease Detection (US$ Mn)
12.9.4 China Biomarkers Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12.10 India Market Overview
12.10.1 India Biomarkers Market Revenue Forecasts and Analysis-By Type (US$ Mn)
12.10.1.1 India Biomarkers Type Market Revenue Forecasts and Analysis-By Efficacy Biomarkers (US$ Mn)
12.10.2 India Biomarkers Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.10.3 India Biomarkers Market Revenue Forecasts and Analysis-By Disease Detection (US$ Mn)
12.10.4 India Biomarkers Market Revenue Forecasts and Analysis-By Application (US$ Mn)
13 Middle East and Africa (MEA) Biomarkers Market Revenue and Forecasts to 2025 - Country Analysis
13.1 Middle East & Africa Biomarkers Market Overview
13.2 Middle East & Africa Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
13.3 Middle East & Africa Market Forecasts and Analysis - By Type
13.3.1 Middle East & Africa Market Type Revenue Forecasts and Analysis - By Efficacy Biomarkers (US$ Mn)
13.4 Middle East & Africa Market Forecasts and Analysis - By Product
13.5 Middle East & Africa Market Forecasts and Analysis - By Disease Detection
13.6 Middle East & Africa Market Forecasts and Analysis - By Application
13.7 Middle East & Africa Market Forecasts and Analysis - By Country
13.8 South Africa Market Overview
13.8.1 South Africa Biomarkers Market Revenue Forecasts and Analysis-By Type (US$ Mn)
13.8.1.1 South Africa Biomarkers Type Market Revenue Forecasts and Analysis-By Efficacy Biomarkers (US$ Mn)
13.8.2 South Africa Biomarkers Market Revenue Forecasts and Analysis-By Product (US$ Mn)
13.8.3 South Africa Biomarkers Market Revenue Forecasts and Analysis-By Disease Detection (US$ Mn)
13.8.4 South Africa Biomarkers Market Revenue Forecasts and Analysis-By Application (US$ Mn)
13.9 Saudi Arabia Market Overview
13.9.1 Saudi Arabia Biomarkers Market Revenue Forecasts and Analysis-By Type (US$ Mn)
13.9.1.1 Saudi Arabia Biomarkers Type Market Revenue Forecasts and Analysis-By Efficacy Biomarkers (US$ Mn)
13.9.2 Saudi Arabia Biomarkers Market Revenue Forecasts and Analysis-By Product (US$ Mn)
13.9.3 Saudi Arabia Biomarkers Market Revenue Forecasts and Analysis-By Disease Detection (US$ Mn)
13.9.4 Saudi Arabia Biomarkers Market Revenue Forecasts and Analysis-By Application (US$ Mn)
13.10 UAE Market Overview
13.10.1 UAE Biomarkers Market Revenue Forecasts and Analysis-By Type (US$ Mn)
13.10.1.1 UAE Biomarkers Type Market Revenue Forecasts and Analysis-By Efficacy Biomarkers (US$ Mn)
13.10.2 UAE Biomarkers Market Revenue Forecasts and Analysis-By Product (US$ Mn)
13.10.3 UAE Biomarkers Market Revenue Forecasts and Analysis-By Disease Detection (US$ Mn)
13.10.4 UAE Biomarkers Market Revenue Forecasts and Analysis-By Application (US$ Mn)
14 South and Central America Biomarkers Market Revenue and Forecasts to 2025 - Country Analysis
14.1 South and Central America Biomarkers Market Overview
14.2 South and Central America Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
14.3 South and Central America Market Forecasts and Analysis - By Type
14.3.1 South and Central America Market Type Revenue Forecasts and Analysis - By Efficacy Biomarkers (US$ Mn)
14.4 South and Central America Market Forecasts and Analysis - By Product
14.5 South and Central America Market Forecasts and Analysis - By Disease Detection
14.6 South and Central America Market Forecasts and Analysis - By Application
14.7 South and Central America Market Forecasts and Analysis - By Country
14.8 Brazil Market Overview
14.8.1 Brazil Biomarkers Market Revenue Forecasts and Analysis-By Type (US$ Mn)
14.8.1.1 Brazil Biomarkers Type Market Revenue Forecasts and Analysis-By Efficacy Biomarkers (US$ Mn)
14.8.2 Brazil Biomarkers Market Revenue Forecasts and Analysis-By Product (US$ Mn)
14.8.3 Brazil Biomarkers Market Revenue Forecasts and Analysis-By Disease Detection (US$ Mn)
14.8.4 Brazil Biomarkers Market Revenue Forecasts and Analysis-By Application (US$ Mn)
15 Industry Landscape
15.1 Organic Growth Strategies
15.1.1 New Type Launches
15.1.2 Marketing & Promotional Activities
15.2 Inorganic Growth Strategies
15.2.1 Partnerships, Collaborations, and Joint Ventures
15.2.2 Mergers & Acquisitions
15.2.3 Geographic Expansions
16 Biomarkers Market, Key Company Profiles
16.1 Thermo Fisher scientific Inc.
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Financial Overview
16.1.4 Product Portfolio
16.1.5 Product Pipeline
16.1.6 SWOT Analysis
16.1.7 Key Developments
16.2 Qiagen
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Financial Overview
16.2.4 Product Portfolio
16.2.5 Product Pipeline
16.2.6 SWOT Analysis
16.2.7 Key Developments
16.3 Hologic Inc.
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Financial Overview
16.3.4 Product Portfolio
16.3.5 Product Pipeline
16.3.6 SWOT Analysis
16.3.7 Key Developments
16.4 Siemens Healthcare GmbH
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Financial Overview
16.4.4 Product Portfolio
16.4.5 Product Pipeline
16.4.6 SWOT Analysis
16.4.7 Key Developments
16.5 F. Hoffmann-La Roche Ltd
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Financial Overview
16.5.4 Product Portfolio
16.5.5 Product Pipeline
16.5.6 SWOT Analysis
16.5.7 Key Developments
16.6 Janssen Global Services, LLC
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Financial Overview
16.6.4 Product Portfolio
16.6.5 Product Pipeline
16.6.6 SWOT Analysis
16.6.7 Key Developments
16.7 Cisbio
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Financial Overview
16.7.4 Product Portfolio
16.7.5 Product Pipeline
16.7.6 SWOT Analysis
16.7.7 Key Developments
16.8 Biomarker Technologies, Inc.
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Financial Overview
16.8.4 Product Portfolio
16.8.5 Product Pipeline
16.8.6 SWOT Analysis
16.8.7 Key Developments
16.9 Becton, Dickinson and Company
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Financial Overview
16.9.4 Product Portfolio
16.9.5 Product Pipeline
16.9.6 SWOT Analysis
16.9.7 Key Developments
16.10 Bio-Rad Laboratories, Inc.
16.10.1 Key Facts
16.10.2 Business Description
16.10.3 Financial Overview
16.10.4 Product Portfolio
16.10.5 Product Pipeline
16.10.6 SWOT Analysis
16.10.7 Key Developments
17 Appendix
17.1 About The Insight Partners
17.2 Glossary of Terms
17.3 Research Methodology
Healthcare
1.1 Scope of Study
1.2 The Insight Partners Research Report Guidance
2 Key Takeaways
3 Biomarkers Market Landscape
3.1 Market Overview
3.2 Market Segmentation
3.2.1 Biomarkers Market - By Type
3.2.2 Biomarkers Market - By Product
3.2.3 Biomarkers Market - By Disease Detection
3.2.4 Biomarkers Market - By Application
3.2.5 Biomarkers Market - By Region
3.2.5.1 By Country
3.3 PEST Analysis
3.3.1 North America - PEST Analysis
3.3.2 Europe - PEST Analysis
3.3.3 Asia Pacific - PEST Analysis
3.3.4 Middle East and Africa - PEST Analysis
3.3.5 South and Central America - PEST Analysis
4 Biomarkers Market - Key Industry Dynamics
4.1 Key Market Drivers
4.2 Key Market Restraints
4.3 Key Market Opportunities
4.4 Future Trends
4.5 Impact Analysis
5 Biomarkers Market - Global Analysis
5.1 Global Biomarkers Market Overview
5.2 Global Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
5.3 Market Positioning/Market Share
5.4 Performance of Key Players
5.5 Clinical Trial Analysis
5.6 Expert Opinions
6 Biomarkers Market Revenue and Forecasts to 2025 - Type (US$ Mn)
6.1 Overview
6.2 Type Market Forecasts and Analysis
6.3 Efficacy Biomarkers Market
6.3.1 Overview
6.3.2 Efficacy Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
6.3.3 Pharmacodynamic Biomarkers Market
6.3.3.1 Overview
6.3.3.2 Pharmacodynamic Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
6.3.4 Prognostic Biomarkers Market
6.3.4.1 Overview
6.3.4.2 Prognostic Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
6.3.5 Predictive Biomarkers Market
6.3.5.1 Overview
6.3.5.2 Predictive Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
6.4 Safety Biomarkers Market
6.4.1 Overview
6.4.2 Safety Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
6.5 Validation Biomarkers Market
6.5.1 Overview
6.5.2 Validation Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
7 Biomarkers Market Revenue and Forecasts to 2025 - Product (US$ Mn)
7.1 Overview
7.2 Product Market Forecasts and Analysis
7.3 Software Market
7.3.1 Overview
7.3.2 Software Market Revenue Forecasts and Analysis (US$ Mn)
7.4 Services Market
7.4.1 Overview
7.4.2 Services Market Revenue Forecasts and Analysis (US$ Mn)
7.5 Consumables Market
7.5.1 Overview
7.5.2 Consumables Market Revenue Forecasts and Analysis (US$ Mn)
8 Biomarkers Market Revenue and Forecasts to 2025 - Disease Detection (US$ Mn)
8.1 Overview
8.2 Disease Detection Market Forecasts and Analysis
8.3 Cancer Market
8.3.1 Overview
8.3.2 Cancer Market Revenue Forecasts and Analysis (US$ Mn)
8.4 Neurological Disease Market
8.4.1 Overview
8.4.2 Neurological Disease Market Revenue Forecasts and Analysis (US$ Mn)
8.5 Immunological Disease Market
8.5.1 Overview
8.5.2 Immunological Disease Market Revenue Forecasts and Analysis (US$ Mn)
8.6 Cardiovascular Disease Market
8.6.1 Overview
8.6.2 Cardiovascular Disease Market Revenue Forecasts and Analysis (US$ Mn)
8.7 Other Disease Detections Market
8.7.1 Overview
8.7.2 Other Disease Market Revenue Forecasts and Analysis (US$ Mn)
9 Biomarkers Market Revenue and Forecasts to 2025 - Application (US$ Mn)
9.1 Overview
9.2 Application Market Forecasts and Analysis
9.3 Drug Discovery Market
9.3.1 Overview
9.3.2 Drug Discovery Market Revenue Forecasts and Analysis (US$ Mn)
9.4 Personalized Medicine Market
9.4.1 Overview
9.4.2 Personalized Medicine Market Revenue Forecasts and Analysis (US$ Mn)
9.5 Diagnostic Development Market
9.5.1 Overview
9.5.2 Diagnostic Development Market Revenue Forecasts and Analysis (US$ Mn)
9.6 Disease Risk Assessment Market
9.6.1 Overview
9.6.2 Disease Risk Assessment Market Revenue Forecasts and Analysis (US$ Mn)
9.7 Other Applications Market
9.7.1 Overview
9.7.2 Other Applications Market Revenue Forecasts and Analysis (US$ Mn)
10 North America Biomarkers Market Revenue and Forecasts to 2025 - Country Analysis
10.1 North America Biomarkers Market Overview
10.2 North America Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
10.3 North America Market Forecasts and Analysis - By Type
10.3.1 North America Market Type Revenue Forecasts and Analysis - By Efficacy Biomarkers (US$ Mn)
10.4 North America Market Forecasts and Analysis - By Product
10.5 North America Market Forecasts and Analysis - By Disease Detection
10.6 North America Market Forecasts and Analysis - By Application
10.7 North America Market Forecasts and Analysis - By Country
10.8 US Market Overview
10.8.1 US Biomarkers Market Revenue Forecasts and Analysis-By Type (US$ Mn)
10.8.1.1 US Biomarkers Type Market Revenue Forecasts and Analysis-By Efficacy Biomarkers (US$ Mn)
10.8.2 US Biomarkers Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.8.3 US Biomarkers Market Revenue Forecasts and Analysis-By Disease Detection (US$ Mn)
10.8.4 US Biomarkers Market Revenue Forecasts and Analysis-By Application (US$ Mn)
10.9 Canada Market Overview
10.9.1 Canada Biomarkers Market Revenue Forecasts and Analysis-By Type (US$ Mn)
10.9.1.1 Canada Biomarkers Type Market Revenue Forecasts and Analysis-By Efficacy Biomarkers (US$ Mn)
10.9.2 Canada Biomarkers Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.9.3 Canada Biomarkers Market Revenue Forecasts and Analysis-By Disease Detection (US$ Mn)
10.9.4 Canada Biomarkers Market Revenue Forecasts and Analysis-By Application (US$ Mn)
10.10 Mexico Market Overview
10.10.1 Mexico Biomarkers Market Revenue Forecasts and Analysis-By Type (US$ Mn)
10.10.1.1 Mexico Biomarkers Type Market Revenue Forecasts and Analysis-By Efficacy Biomarkers (US$ Mn)
10.10.2 Mexico Biomarkers Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.10.3 Mexico Biomarkers Market Revenue Forecasts and Analysis-By Disease Detection (US$ Mn)
10.10.4 Mexico Biomarkers Market Revenue Forecasts and Analysis-By Application (US$ Mn)
`
11 Europe Biomarkers Market Revenue and Forecasts to 2025 - Country Analysis
11.1 Europe Biomarkers Market Overview
11.2 Europe Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
11.3 Europe Market Forecasts and Analysis - By Type
11.3.1 Europe Market Type Revenue Forecasts and Analysis - By Efficacy Biomarkers (US$ Mn)
11.4 Europe Market Forecasts and Analysis - By Product
11.5 Europe Market Forecasts and Analysis - By Disease Detection
11.6 Europe Market Forecasts and Analysis - By Application
11.7 Europe Market Forecasts and Analysis - By Country
11.8 UK Market Overview
11.8.1 UK Biomarkers Market Revenue Forecasts and Analysis-By Type (US$ Mn)
11.8.1.1 UK Biomarkers Type Market Revenue Forecasts and Analysis-By Efficacy Biomarkers (US$ Mn)
11.8.2 UK Biomarkers Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.8.3 UK Biomarkers Market Revenue Forecasts and Analysis-By Disease Detection (US$ Mn)
11.8.4 UK Biomarkers Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.9 Germany Market Overview
11.9.1 Germany Biomarkers Market Revenue Forecasts and Analysis-By Type (US$ Mn)
11.9.1.1 Germany Biomarkers Type Market Revenue Forecasts and Analysis-By Efficacy Biomarkers (US$ Mn)
11.9.2 Germany Biomarkers Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.9.3 Germany Biomarkers Market Revenue Forecasts and Analysis-By Disease Detection (US$ Mn)
11.9.4 Germany Biomarkers Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.10 France Market Overview
11.10.1 France Biomarkers Market Revenue Forecasts and Analysis-By Type (US$ Mn)
11.10.1.1 France Biomarkers Type Market Revenue Forecasts and Analysis-By Efficacy Biomarkers (US$ Mn)
11.10.2 France Biomarkers Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.10.3 France Biomarkers Market Revenue Forecasts and Analysis-By Disease Detection (US$ Mn)
11.10.4 France Biomarkers Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12 Asia Pacific Biomarkers Market Revenue and Forecasts to 2025 - Country Analysis
12.1 Asia Pacific Biomarkers Market Overview
12.2 Asia Pacific Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
12.3 Asia Pacific Market Forecasts and Analysis - By Type
12.3.1 Asia Pacific Market Type Revenue Forecasts and Analysis - By Efficacy Biomarkers (US$ Mn)
12.4 Asia Pacific Market Forecasts and Analysis - By Product
12.5 Asia Pacific Market Forecasts and Analysis - By Disease Detection
12.6 Asia Pacific Market Forecasts and Analysis - By Application
12.7 Asia Pacific Market Forecasts and Analysis - By Country
12.8 Japan Market Overview
12.8.1 Japan Biomarkers Market Revenue Forecasts and Analysis-By Type (US$ Mn)
12.8.1.1 Japan Biomarkers Type Market Revenue Forecasts and Analysis-By Efficacy Biomarkers (US$ Mn)
12.8.2 Japan Biomarkers Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.8.3 Japan Biomarkers Market Revenue Forecasts and Analysis-By Disease Detection (US$ Mn)
12.8.4 Japan Biomarkers Market Revenue Forecasts and Analysis-By Application (US$ Mn)
?
12.9 China Market Overview
12.9.1 China Biomarkers Market Revenue Forecasts and Analysis-By Type (US$ Mn)
12.9.1.1 China Biomarkers Type Market Revenue Forecasts and Analysis-By Efficacy Biomarkers (US$ Mn)
12.9.2 China Biomarkers Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.9.3 China Biomarkers Market Revenue Forecasts and Analysis-By Disease Detection (US$ Mn)
12.9.4 China Biomarkers Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12.10 India Market Overview
12.10.1 India Biomarkers Market Revenue Forecasts and Analysis-By Type (US$ Mn)
12.10.1.1 India Biomarkers Type Market Revenue Forecasts and Analysis-By Efficacy Biomarkers (US$ Mn)
12.10.2 India Biomarkers Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.10.3 India Biomarkers Market Revenue Forecasts and Analysis-By Disease Detection (US$ Mn)
12.10.4 India Biomarkers Market Revenue Forecasts and Analysis-By Application (US$ Mn)
13 Middle East and Africa (MEA) Biomarkers Market Revenue and Forecasts to 2025 - Country Analysis
13.1 Middle East & Africa Biomarkers Market Overview
13.2 Middle East & Africa Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
13.3 Middle East & Africa Market Forecasts and Analysis - By Type
13.3.1 Middle East & Africa Market Type Revenue Forecasts and Analysis - By Efficacy Biomarkers (US$ Mn)
13.4 Middle East & Africa Market Forecasts and Analysis - By Product
13.5 Middle East & Africa Market Forecasts and Analysis - By Disease Detection
13.6 Middle East & Africa Market Forecasts and Analysis - By Application
13.7 Middle East & Africa Market Forecasts and Analysis - By Country
13.8 South Africa Market Overview
13.8.1 South Africa Biomarkers Market Revenue Forecasts and Analysis-By Type (US$ Mn)
13.8.1.1 South Africa Biomarkers Type Market Revenue Forecasts and Analysis-By Efficacy Biomarkers (US$ Mn)
13.8.2 South Africa Biomarkers Market Revenue Forecasts and Analysis-By Product (US$ Mn)
13.8.3 South Africa Biomarkers Market Revenue Forecasts and Analysis-By Disease Detection (US$ Mn)
13.8.4 South Africa Biomarkers Market Revenue Forecasts and Analysis-By Application (US$ Mn)
13.9 Saudi Arabia Market Overview
13.9.1 Saudi Arabia Biomarkers Market Revenue Forecasts and Analysis-By Type (US$ Mn)
13.9.1.1 Saudi Arabia Biomarkers Type Market Revenue Forecasts and Analysis-By Efficacy Biomarkers (US$ Mn)
13.9.2 Saudi Arabia Biomarkers Market Revenue Forecasts and Analysis-By Product (US$ Mn)
13.9.3 Saudi Arabia Biomarkers Market Revenue Forecasts and Analysis-By Disease Detection (US$ Mn)
13.9.4 Saudi Arabia Biomarkers Market Revenue Forecasts and Analysis-By Application (US$ Mn)
13.10 UAE Market Overview
13.10.1 UAE Biomarkers Market Revenue Forecasts and Analysis-By Type (US$ Mn)
13.10.1.1 UAE Biomarkers Type Market Revenue Forecasts and Analysis-By Efficacy Biomarkers (US$ Mn)
13.10.2 UAE Biomarkers Market Revenue Forecasts and Analysis-By Product (US$ Mn)
13.10.3 UAE Biomarkers Market Revenue Forecasts and Analysis-By Disease Detection (US$ Mn)
13.10.4 UAE Biomarkers Market Revenue Forecasts and Analysis-By Application (US$ Mn)
14 South and Central America Biomarkers Market Revenue and Forecasts to 2025 - Country Analysis
14.1 South and Central America Biomarkers Market Overview
14.2 South and Central America Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
14.3 South and Central America Market Forecasts and Analysis - By Type
14.3.1 South and Central America Market Type Revenue Forecasts and Analysis - By Efficacy Biomarkers (US$ Mn)
14.4 South and Central America Market Forecasts and Analysis - By Product
14.5 South and Central America Market Forecasts and Analysis - By Disease Detection
14.6 South and Central America Market Forecasts and Analysis - By Application
14.7 South and Central America Market Forecasts and Analysis - By Country
14.8 Brazil Market Overview
14.8.1 Brazil Biomarkers Market Revenue Forecasts and Analysis-By Type (US$ Mn)
14.8.1.1 Brazil Biomarkers Type Market Revenue Forecasts and Analysis-By Efficacy Biomarkers (US$ Mn)
14.8.2 Brazil Biomarkers Market Revenue Forecasts and Analysis-By Product (US$ Mn)
14.8.3 Brazil Biomarkers Market Revenue Forecasts and Analysis-By Disease Detection (US$ Mn)
14.8.4 Brazil Biomarkers Market Revenue Forecasts and Analysis-By Application (US$ Mn)
15 Industry Landscape
15.1 Organic Growth Strategies
15.1.1 New Type Launches
15.1.2 Marketing & Promotional Activities
15.2 Inorganic Growth Strategies
15.2.1 Partnerships, Collaborations, and Joint Ventures
15.2.2 Mergers & Acquisitions
15.2.3 Geographic Expansions
16 Biomarkers Market, Key Company Profiles
16.1 Thermo Fisher scientific Inc.
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Financial Overview
16.1.4 Product Portfolio
16.1.5 Product Pipeline
16.1.6 SWOT Analysis
16.1.7 Key Developments
16.2 Qiagen
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Financial Overview
16.2.4 Product Portfolio
16.2.5 Product Pipeline
16.2.6 SWOT Analysis
16.2.7 Key Developments
16.3 Hologic Inc.
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Financial Overview
16.3.4 Product Portfolio
16.3.5 Product Pipeline
16.3.6 SWOT Analysis
16.3.7 Key Developments
16.4 Siemens Healthcare GmbH
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Financial Overview
16.4.4 Product Portfolio
16.4.5 Product Pipeline
16.4.6 SWOT Analysis
16.4.7 Key Developments
16.5 F. Hoffmann-La Roche Ltd
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Financial Overview
16.5.4 Product Portfolio
16.5.5 Product Pipeline
16.5.6 SWOT Analysis
16.5.7 Key Developments
16.6 Janssen Global Services, LLC
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Financial Overview
16.6.4 Product Portfolio
16.6.5 Product Pipeline
16.6.6 SWOT Analysis
16.6.7 Key Developments
16.7 Cisbio
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Financial Overview
16.7.4 Product Portfolio
16.7.5 Product Pipeline
16.7.6 SWOT Analysis
16.7.7 Key Developments
16.8 Biomarker Technologies, Inc.
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Financial Overview
16.8.4 Product Portfolio
16.8.5 Product Pipeline
16.8.6 SWOT Analysis
16.8.7 Key Developments
16.9 Becton, Dickinson and Company
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Financial Overview
16.9.4 Product Portfolio
16.9.5 Product Pipeline
16.9.6 SWOT Analysis
16.9.7 Key Developments
16.10 Bio-Rad Laboratories, Inc.
16.10.1 Key Facts
16.10.2 Business Description
16.10.3 Financial Overview
16.10.4 Product Portfolio
16.10.5 Product Pipeline
16.10.6 SWOT Analysis
16.10.7 Key Developments
17 Appendix
17.1 About The Insight Partners
17.2 Glossary of Terms
17.3 Research Methodology
Healthcare
The List of Companies
1. Thermo Fisher Scientific Inc.
2. Qiagen
3. Hologic Inc.
4. F. Hoffmann-La Roche Ltd
5. Janssen Global Services, LLC
6. Siemens Healthcare GmbH
7. Cisbio
8. Biomarker Technologies, Inc.
9. Becton, Dickinson and Company
10. Bio-Rad Laboratories, Inc.
1. Thermo Fisher Scientific Inc.
2. Qiagen
3. Hologic Inc.
4. F. Hoffmann-La Roche Ltd
5. Janssen Global Services, LLC
6. Siemens Healthcare GmbH
7. Cisbio
8. Biomarker Technologies, Inc.
9. Becton, Dickinson and Company
10. Bio-Rad Laboratories, Inc.